Joseph R. Palmeri

Sequence and structural determinants of efficacious de novo chimaeric antigen receptors.

Advances in generative protein design using artificial intelligence (AI) have enabled the rapid development of binders against heterogeneous targets, including tumour-associated antigens. Despite extensive biochemical characterization, these novel protein binders have had limited evaluation in candidate therapeutics, i...